AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Medicare Drug Price Negotiations: Impacts and Implications
This chapter explores upcoming Medicare drug pricing changes, highlighting the anticipated $6 billion savings from negotiations set for 2026 and reforms to cap out-of-pocket costs for beneficiaries. It discusses both the immediate benefits for patients and the broader implications for pharmaceutical innovation and access to medications. The chapter also addresses concerns regarding the role of pharmacy benefit managers and the need for compliance to ensure that beneficiaries benefit from these negotiated prices.